The findings regarding the effects of metformin in suppressing gut inflammation in a colitis model also support our conclusion.34 Besides the mTOR signaling pathway, key enzymes in the glutamine metabolic pathway, such as glutaminase, are also potential targets for targeted therapy of inflammation caused by high fructose intake. The gene discussed is GLS; the disease is colitis.